Glucose-sensitive albumin-binding derivatives
US-2025122226-A1 · Apr 17, 2025 · US
This page is not indexed by search engines while we improve data quality.
Kruse Thomas patents
Kruse Thomas is listed as an inventor on 59 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Kruse Thomas |
| Total patents | 59 |
| First publication | Jan 22, 2015 |
| Latest publication | Apr 17, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Glucose-sensitive albumin-binding derivatives
US-12227528-B2 · Feb 18, 2025 · US
Amylin receptor agonists
US-12116388-B2 · Oct 15, 2024 · US
Co-agonists of the glp-1 and amylin receptors
US-2024279299-A1 · Aug 22, 2024 · US
Co-agonists of the GLP-1 and amylin receptors
US-12054528-B2 · Aug 6, 2024 · US
Amylin receptor agonists
US-2024239852-A1 · Jul 18, 2024 · US
Co-agonists of the glp-1 and amylin receptors
US-2023331803-A1 · Oct 19, 2023 · US
Glucose-sensitive albumin-binding derivatives
US-2023331745-A1 · Oct 19, 2023 · US
Glucose-sensitive albumin-binding derivatives
US-11767332-B2 · Sep 26, 2023 · US
Glucose sensitive insulin derivatives
US-2022184184-A1 · Jun 16, 2022 · US
Recent patents
Latest publications not already listed above.
Glucose-sensitive albumin-binding derivatives
US-2022081451-A1 · Mar 17, 2022 · US
Glucose-sensitive albumin-binding derivatives
US-11186595-B2 · Nov 30, 2021 · US
Double-acylated GLP-1 derivatives
US-11117947-B2 · Sep 14, 2021 · US
Double-acylated GLP-1 derivatives
US-11034746-B2 · Jun 15, 2021 · US
Canopy structure and a wind turbine
US-11009008-B2 · May 18, 2021 · US
Glucose-sensitive albumin-binding derivatives
US-2020325160-A1 · Oct 15, 2020 · US
Compounds For Use in NASH
US-2020268835-A1 · Aug 27, 2020 · US
Double-acylated glp-1 derivatives
US-2020079834-A1 · Mar 12, 2020 · US
GLP-1/glucagon receptor co-agonists for medical use
US-10570184-B2 · Feb 25, 2020 · US
Canopy structure and a wind turbine
US-2019271297-A1 · Sep 5, 2019 · US
Amylin and calcitonin receptor agonist
US-10174082-B2 · Jan 8, 2019 · US
Double-Acylated GLP-1 Derivatives
US-2018251512-A1 · Sep 6, 2018 · US
Double-acylated GLP-1 derivatives
US-10005827-B2 · Jun 26, 2018 · US
Stable GLP-1 based GLP-1/glucagon receptor co-agonists
US-9988430-B2 · Jun 5, 2018 · US
Stable glucagon analogues and use for treatment of hypoglycaemia
US-9963496-B2 · May 8, 2018 · US
Stable, protracted glp-1/glucagon receptor co-agonists for medical use
US-2018044394-A1 · Feb 15, 2018 · US
Acylated Glucagon Analogues
US-2018016319-A1 · Jan 18, 2018 · US
Stable, protracted GLP-1/glucagon receptor co-agonists for medical use
US-9751927-B2 · Sep 5, 2017 · US
Semi-recombinant preparation of GLP-1 analogues
US-9732137-B2 · Aug 15, 2017 · US
Double-acylated GLP-1 derivatives
US-9708383-B2 · Jul 18, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novo Nordisk As | 57 |
| Lau Jesper | 3 |
| Garibay Patrick William | 3 |
| Kruse Thomas | 3 |
| Siemens Gamesa Renewable Energy As | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P3/10 | 48 |
| C07K14/605 | 40 |
| A61K38/00 | 38 |
| A61P3/04 | 38 |
| A61K38/26 | 31 |